Table 1.

Demographic and clinical characteristics of adults with severe obesity prior to bariatric surgery, by sex.

Characteristic	Female (N=1751)a		Male (N=474)a
	n	% b	n	% b
Age, years, median (25th, 75th percentile)	45.0	(36.0, 53.0)	48.0	(39.0, 57.0)
Age group, years
<30	158	9.0	28	5.9
30–39	452	25.8	99	20.9
40–49	494	28.2	126	26.6
50–59	474	27.1	133	28.1
≥60	173	9.9	88	18.6
Race
White	1483	85.6	434	92.7
Black	191	11.0	26	5.6
Other	59	3.4	8	1.7
Hispanic/Latino ethnicity
Yes	93	5.3	18	3.8
No	1657	94.7	455	96.2
Education
High school or less	399	22.9	106	22.5
Some college/post high school education	713	40.9	186	39.4
College degree or higher	630	36.2	180	38.1
Marital status
Married/living as married	1081	62.1	338	71.5
Divorced/separated	332	19.1	62	13.1
Widowed	43	2.5	3	0.6
Never married	285	16.4	70	14.8
Current or recent smoker
Yes	239	13.7	52	11.0
No	1510	86.3	421	89.0
Alcohol use disorder symptoms
Yes	111	6.4	34	7.2
No	1629	93.6	438	92.8
Body mass index, kg/m2, median (25th, 75th percentile)	45.6	(41.6, 50.9)	47.3	(42.6, 53.0)
Beck Depression Inventory Score, median (25th, 75th percentile)	6.0	(3.0, 11.0)	5.0	(2.0, 10.0)
missing	98		29
Diabetes
Yes	527	31.2	216	47.1
Without insulin	336	20.2	109	24.7
With insulin	163	9.8	90	20.4
No	1164	68.8	243	52.9
Hypertension
Yes	1120	64.7	378	80.4
No	610	35.3	92	19.6
Dyslipidemia
Yes	975	61.7	355	75.1
No	604	38.3	118	24.9
Sleep apnea
Yes	821	46.9	355	75.1
No	929	53.1	118	24.9
Cardiovascular disease
Yes	91	5.2	86	18.2
No	1653	94.8	387	81.8
Urinary Incontinence
Yes	849	48.8	100	21.4
No	891	51.2	368	78.6
Menopausal status			NA	NA
No	934	53.3
Yes	511	29.2
Unknown	306	17.5
Number of prior live or still births			NA	NA
0	423	26.5
1	263	16.5
2	496	31.1
3 or more	412	25.8
Medications that may improve sexual function a	121	7.0	34	7.4
Antidepressant medications that may decrease sexual function b	621	36.3	116	25.3
Antihypertensive medications that may decrease sexual function c	NA	NA	160	34.9
Other hormonal meds that may affect sexual functiond	114	6.6	NA	NA

NA= not applicable

Values are expressed as number (%) unless otherwise indicated. The number of participants across categories may not sum to the total number of participants due to missing data.

^aPhosphodiesterase type 5 inhibitors and bupropion. Among men only, also androgens.

^bAntidepressant medications other than bupropion, trazodone, mirtazapine or nefazodone.

^cBeta-adrenergic blockers and diuretics.

^dEstrogens, progestins, and androgens, either alone or in combination.